Am J Surg
- HANUSCHAK D, DePiero M, DeMoraes M, Bailly S, et al
The impact of COVID-19 on patients diagnosed with melanoma, breast, and
colorectal cancer.
Am J Surg. 2023 Sep 29:S0002-9610(23)00496-8. doi: 10.1016/j.amjsurg.2023.
Ann Surg Oncol
- CHUNG A
ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in
Older Patients with ER+/Her2- Breast Cancer.
Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15095.
- BARKER VR, Naffouje SA, Mallory MA, Hoover SA, et al
ASO Visual Abstract: Surgical Management of the Axilla in HR+/HER2-Breast Cancer
in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer
Database.
Ann Surg Oncol. 2024 Feb 19. doi: 10.1245/s10434-024-15063.
- CHUN JW, Kang E, Kim HK, Lee HB, et al
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with
Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15049.
- LAWS A, Leonard S, Hershey E, Stokes S, et al
ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline
Pathogenic Variant Carriers with High-Risk Breast Lesions.
Ann Surg Oncol. 2024 Feb 16. doi: 10.1245/s10434-024-15067.
BMC Cancer
- ABEDI M, Sahebi L, Eslami B, Saberi A, et al
Using a combination of superb microvascular imaging and other auxiliary
ultrasound techniques to increase the accuracy of gray-scale ultrasound for
breast masses.
BMC Cancer. 2024;24:224.
- BEN-ZION BERLINER M, Yust-Katz S, Lavie I, Goldberg Y, et al
Central nervous system metastases in breast cancer patients with germline BRCA
pathogenic variants compared to non-carriers: a matched-pair analysis.
BMC Cancer. 2024;24:219.
Br J Cancer
- YU T, Yang C, Li M
Comment on "Pathological complete response, category change, and prognostic
significance of HER2-low breast cancer receiving neoadjuvant treatment: a
multicenter analysis of 2489 cases".
Br J Cancer. 2024 Feb 20. doi: 10.1038/s41416-024-02616.
Breast Cancer
- KIM N, Cho WK, Park W, Lee JE, et al
Outcomes of whole breast radiation therapy in Asian breast cancer patients with
prior cosmetic implants.
Breast Cancer. 2024 Feb 18. doi: 10.1007/s12282-024-01547.
Breast Cancer (Auckl)
- KHALID IB, Sarwar A, Khalid HB, Sajjad B, et al
Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in
Pakistani Population: A 10-Year Retrospective Cross-Sectional Study.
Breast Cancer (Auckl). 2024;18:11782234241233120.
Breast Cancer Res
- HEESCH A, Florea A, Maurer J, Habib P, et al
The prostate-specific membrane antigen holds potential as a vascular target for
endogenous radiotherapy with [(177)Lu]Lu-PSMA-I&T for triple-negative breast
cancer.
Breast Cancer Res. 2024;26:30.
- DEROUANE F, Desgres M, Moroni C, Ambroise J, et al
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant
chemotherapy in early triple negative breast cancers.
Breast Cancer Res. 2024;26:29.
- SCHEFFGES C, Devy J, Giustiniani J, Francois S, et al
Identification of CD160-TM as a tumor target on triple negative breast cancers:
possible therapeutic applications.
Breast Cancer Res. 2024;26:28.
Breast Cancer Res Treat
- CHEN Y, Markowitz JC, Blanco C, Hershman DL, et al
Geographical distance predicts psychiatric treatment retention for Hispanic women
with comorbid major depression and breast cancer.
Breast Cancer Res Treat. 2024 Feb 20. doi: 10.1007/s10549-024-07250.
- BUFMAN H, Faermann R, Halshtok-Neiman O, Shalmon A, et al
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic
sequence variant carriers: a single institution experience.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-023-07234.
- GEURTS SME, Ibragimova KIE, Ding N, Meegdes M, et al
Time trends in real-world treatment patterns and survival in patients diagnosed
with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-023-07235.
- FALEH S, Prakash I, Salehi A, Khan H, et al
Preoperative factors that predict pathologic nodal involvement in early-stage
HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant
chemotherapy versus upfront surgery.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-024-07251.
Cancer Lett
- MURTHY D, Dutta D, Attri KS, Samanta T, et al
CD24 negativity reprograms mitochondrial metabolism to PPARalpha and NF-kappaB-driven
fatty acid beta-oxidation in triple-negative breast cancer.
Cancer Lett. 2024 Feb 17:216724. doi: 10.1016/j.canlet.2024.216724.
Cancer Res
- YAMAMOTO T, Hayashida T, Masugi Y, Oshikawa K, et al
PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive
chemoresistance in triple-negative breast cancer.
Cancer Res. 2024 Feb 22. doi: 10.1158/0008-5472.CAN-23-2266.
Clin Breast Cancer
- ZHU Z, Wang H, Qian X, Xue M, et al
Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis:
Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated
FAK/STAT3 Signaling.
Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00025.
- LIU D, Chang L, Zhao X, Dai L, et al
Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer
Patients With 1-2 Sentinel Lymph Node Metastases.
Clin Breast Cancer. 2024 Jan 24:S1526-8209(24)00022.
Clin Cancer Res
- GUARDUCCI C, Nardone A, Russo D, Nagy Z, et al
Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling
while enhancing apoptosis in therapy-resistant estrogen receptor positive breast
cancer.
Clin Cancer Res. 2024 Feb 21. doi: 10.1158/1078-0432.CCR-23-2975.
- MAMOUNAS EP, Bandos H, Rastogi P, Zhang Y, et al
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy
Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP
B-42 Trial.
Clin Cancer Res. 2024 Feb 20. doi: 10.1158/1078-0432.CCR-23-1977.
Clin Exp Metastasis
- POURJAMAL N, Yazdi N, Halme A, Joncour VL, et al
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab
vedotin in a multiresistant HER2-positive breast cancer lung metastasis model.
Clin Exp Metastasis. 2024 Feb 17. doi: 10.1007/s10585-024-10278.
Clin Med Insights Oncol
- ABULKHAIR O, Omair A, Makanjuola D, Al Zaid M, et al
Breast Cancer in Young Women: Is It Different? A Single-Center Retrospective
Cohort Study.
Clin Med Insights Oncol. 2024;18:11795549241228235.
Eur J Cancer
- TARANTINO P, Ajari O, Graham N, Vincuilla J, et al
Evolution of HER2 expression between pre-treatment biopsy and residual disease
after neoadjuvant therapy for breast cancer.
Eur J Cancer. 2024;201:113920.
Eur Radiol
- JING X, Dorrius MD, Zheng S, Wielema M, et al
Localization of contrast-enhanced breast lesions in ultrafast screening MRI using
deep convolutional neural networks.
Eur Radiol. 2024;34:2084-2092.
- LOKAJ B, Pugliese MT, Kinkel K, Lovis C, et al
Barriers and facilitators of artificial intelligence conception and
implementation for breast imaging diagnosis in clinical practice: a scoping
review.
Eur Radiol. 2024;34:2096-2109.
- SEKER ME, Koyluoglu YO, Ozaydin AN, Gurdal SO, et al
Diagnostic capabilities of artificial intelligence as an additional reader in a
breast cancer screening program.
Eur Radiol. 2024 Feb 22. doi: 10.1007/s00330-024-10661.
Int J Radiat Oncol Biol Phys
- CACHO-DIAZ B, Tripathy D, Arrieta VA, Escamilla-Ramirez A, et al
Real-world experience in Hispanic Patients with Breast Cancer and Brain
Metastases using different Prognostic Tools.
Int J Radiat Oncol Biol Phys. 2024 Feb 14:S0360-3016(24)00305.
J Clin Oncol
- SHAH M, Lingam H, Gao X, Gittleman H, et al
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen
Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative,
ESR1-Mutated Advanced or Metastatic Breast Cancer.
J Clin Oncol. 2024 Feb 21:JCO2302112. doi: 10.1200/JCO.23.02112.
J Natl Cancer Inst
- XIAO Q, Mao X, Ploner A, Grassmann F, et al
Cancer risks among first-degree relatives of women with a genetic predisposition
to breast cancer.
J Natl Cancer Inst. 2024 Feb 14:djae030. doi: 10.1093.
J Surg Oncol
- KIM M, Carter J, Tadros AB, Abuhdra N, et al
A guide for addressing sexual health in breast cancer patients.
J Surg Oncol. 2024 Feb 22. doi: 10.1002/jso.27602.
Mod Pathol
- AL ASSAAD M, Michaud O, Semaan A, Sigouros M, et al
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural
Events and Potential Therapeutic Targets.
Mod Pathol. 2024 Feb 16:100452. doi: 10.1016/j.modpat.2024.100452.
NPJ Breast Cancer
- MENG P, Dalal H, Chen Y, Brueffer C, et al
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast
cancer survival after trastuzumab.
NPJ Breast Cancer. 2024;10:14.
- CHAUDHARY N, Chibly AM, Collier A, Martinalbo J, et al
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation
prevalence and more altered genomic landscape.
NPJ Breast Cancer. 2024;10:15.
Oncogene
- REID SE, Pantaleo J, Bolivar P, Bocci M, et al
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal
breast cancer, enabling estrogen independence.
Oncogene. 2024 Feb 22. doi: 10.1038/s41388-024-02973.
- LIANG Y, Chen B, Xu F, Long L, et al
LncRNA PRBC induces autophagy to promote breast cancer progression through
modulating PABPC1-mediated mRNA stabilization.
Oncogene. 2024 Feb 16. doi: 10.1038/s41388-024-02971.
Pathology
- KRYSTEL-WHITTEMORE M, Tan PH, Wen HY
Predictive and prognostic biomarkers in breast tumours.
Pathology. 2024;56:186-191.
PLoS Genet
- SCOTT TG, Sathyan KM, Gioeli D, Guertin MJ, et al
TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER)
binding and ER target gene expression in luminal breast cancer cells.
PLoS Genet. 2024;20:e1011159.
Proc Natl Acad Sci U S A
- LAUBLI H
Unraveling the impact of a glyco-immune checkpoint in bone metastasis.
Proc Natl Acad Sci U S A. 2024;121:e2400499121.
Radiol Imaging Cancer
- FIELDS BKK, Joe BN
Screening Breast MRI Effectively Detects Early-Stage Breast Cancer in High-Risk
Patients without Prior History of Breast Cancer.
Radiol Imaging Cancer. 2024;6:e249005.
Radiology
- MONTICCIOLO DL, Hendrick RE, Helvie MA
Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and
Surveillance Modeling Network Estimates.
Radiology. 2024;310:e232658.
Radiother Oncol
- WHELAN TJ, Fyles A, Parpia S, Nielsen T, et al
LUMINA: Using molecular biomarkers to guide decision making for breast
radiotherapy.
Radiother Oncol. 2024;190:110074.
- WINTRAECKEN VM, Boersma LJ, van Roozendaal LM, de Vries J, et al
Quality assurance of radiation therapy after breast-conserving surgery among
patients in the BOOG 2013-08 trial.
Radiother Oncol. 2024;191:110069.
- OLLONI A, Lorenzen EL, Jeppesen SS, Diederichsen A, et al
An open source auto-segmentation algorithm for delineating heart and
substructures - Development and validation within a multicenter lung cancer
cohort.
Radiother Oncol. 2024;191:110065.
- MEATTINI I, Marta GN, Carroll S, Rivera S, et al
Omission of radiation therapy after breast-conserving surgery for biologically
favourable tumours in younger patients: The wrong answer to the right question.
Radiother Oncol. 2024;190:110045.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016